|
|
|
|
|
|
|
|
|
|
CNN.com
updated 5:26 PM EDT, Mon April 15, 2013
Washington (CNN) -- It is a case at the intersection of science and finance, an evolving 21st century dispute that comes down to a simple question: Should the government allow patents for human genes?
The Supreme Court offered
little other than confusion during oral arguments on Monday on nine
patents held by a Utah biotech firm.
Myriad Genetics isolated
two related types of biological material, BCRA-1 and BCRA-2, linked to
increased hereditary risk for breast and ovarian cancer.
At issue is whether
"products of nature" can be treated the same as "human-made" inventions,
and held as the exclusive intellectual property of individuals and
companies.
Mapping genes of breast cancer
Who owns your genes?
A ruling is expected by late June.........
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.